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A B S T R A C T
Oxacillin-resistant staphylococci are heterogene-
ous in their expression of resistance to b-lactam
antibiotics. Different recommendations regarding
screening methods for routine use have been
published. In this study, the susceptibility to
oxacillin of 232 coagulase-negative staphylococci
(CoNS) was determined by agar dilution, Etest
and presence of the mecA gene. When an oxacillin
resistance breakpoint of ‡ 0.5 mg ⁄L was used, the
sensitivity and specificity for agar dilution were
97.6% and 100%, and those for Etest were 100%
and 95.4%. The current National Committee for
Clinical Laboratory Standards oxacillin break-
point recommendation will categorise accurately
the CoNS species encountered commonly.
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Coagulase-negative staphylococci (CoNS) are a
significant cause of bacteraemia and other hospi-
tal-acquired infections, especially in immunocom-
promised individuals and patients with prosthetic
implants [1–3]. Many CoNS are resistant to
penicillin and oxacillin because of production of
b-lactamase and penicillin-binding protein 2a
(PBP2a), respectively [4]. Production of PBP2a in
staphylococci is encoded by the mecA gene. PBP2a
has been found in a variety of CoNS, but expres-
sion of mecA is different in CoNS and Staphylo-
coccus aureus. Several groups of investigators have
described DNA probes [5–7] and PCR assays
[8–16] for detection of oxacillin resistance in
staphylococci. Based on the results of some of
these studies, the National Committee for Clinical
Laboratory Standards (NCCLS) has redefined the
breakpoints for oxacillin susceptibility in CoNS
[17]. In the present study, PCR detection of the
mecA gene was compared with Etest and agar
dilution based on the new NCCLS breakpoint for
identification of oxacillin resistance in clinical
isolates of CoNS.
Clinically significant isolates (n ¼ 180) were
collected from 13 Norwegian clinical microbiolo-
gical laboratories over a period of 22 months.
Preliminary identification in the local laboratory
was on the basis of colony morphology, a positive
catalase test, and a negative agglutination test or a
negative DNase test. CoNS blood culture isolates
that had been collected and stored at Haukeland
University Hospital for the previous 2 years were
also included in the study (n ¼ 52). The 232
isolates were from the following sources: blood
culture (160 isolates), venous and arterial cathe-
ters (32), surgical wounds (30), tracheal tubes
(four), spinal fluid (two), peritoneal fluid (two),
pleural fluid (one) and eye secretion (one). All
isolates were identified to the species level by API
Staph 32 ID (bioMe´rieux, Marcy l’Etoile, France)
with an automated reader at Haukeland Univer-
sity Hospital.
Etests (AB Biodisk, Solna, Sweden) were per-
formed following the recommendations of the
Norwegian Working Group on Antibiotics [18].
Agar dilution was performed with Mueller–
Hinton agar (Mast, Bootle, UK) supplemented
with NaCl 2% w ⁄ v, an inoculum of 0.5·
Corresponding author and reprint requests: Y. Tveten,
Telemark Biomedical Centre, A ⁄ S Telelab, Department of
Medical Microbiology, Strømdaljordet 4, PO Box 1868, 3703
Skien, Norway
E-mail: yngvar.tveten@telelab.no
462 Clinical Microbiology and Infection, Volume 10 Number 5, May 2004
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 459–470
McFarland standard, and incubation for 24 h at
34 ± 1 C. MecA PCR was performed as described
by Predari et al. [9] at the Telelab laboratory, with
the following modification in the lysis procedure.
The pellet was resuspended in 100 lL TE buffer
(10 mM Tris-HCl, 1 mM EDTA, pH 8.0) with 10 lL
lysostaphin (15 U ⁄mL). Following incubation
at 37 C for 15 min, 10 lL sodium dodecyl sul-
phate 1%w ⁄ v and 10 lL proteinase K (25 mg ⁄mL
in 50 mM Tris-HCl, pH 8.0) were added, followed
by incubation for a further 15 min at room
temperature.
In total, 125 (53.8%) of the 232 CoNS isolates
were positive for the mecA gene by PCR. Table 1
shows the correlation between agar dilution
MICs and the presence of the mecA gene within
the different CoNS species identified. The current
breakpoint for oxacillin resistance separated the
resistant (mecA-positive) and susceptible (mecA-
negative) populations with satisfactory precision.
Only three mecA-positive isolates had MICs
below the actual breakpoint, with values of
0.25 mg ⁄L. Table 2 shows the correlation
between mecA PCR and susceptibility tests per-
formed by agar dilution and Etest with an
oxacillin breakpoint of ‡ 0.5 mg ⁄L. The sensitiv-
ity for agar dilution was 97.6%, and that for Etest
was 100%. The specificity for agar dilution was
100%, and that for Etest was 95.4%. If the
oxacillin resistance breakpoint had been lowered
to ‡ 0.25 mg ⁄L, the sensitivity for agar dilution
would have reached 100%, but the specificity
would have decreased to 92.6%. The values that
decreased the specificity for the oxacillin Etest
were in the range 0.5–6.0 mg ⁄L.
CoNS are the pathogens isolated most com-
monly from bloodstream infections in intensive
care unit patients [3]. Of 32 CoNS species recog-
nised, only half are seen in clinical specimens.
Among CoNS, S. epidermidis is generally the most
common species [1]. In total, 54% of the isolates
studied were resistant to oxacillin, as determined
by PCR detection of the mecA gene. This value is
lower than in other published reports, which have
detected resistance rates of 70–80% [2]. In the
present study, the sensitivity and specificity of
agar dilution were satisfactory when the current
oxacillin MIC breakpoint of ‡ 0.5 mg ⁄L was used.
Two S. epidermidis and one S. hominis isolate
would have been reported as falsely oxacillin-
Table 1. Correlation between the
oxacillin MIC (agar dilution) for
different CoNS species and the pres-
ence of the mecA gene
Staphylococcus
spp. mecA
No. of isolates
tested
Number with MIC values (mg ⁄L):
£ 0.13 0.25 0.5 1 2 4 ‡ 6
S. epidermidis + 105 2 13 39 21 8 22
– 71 68 3
S. hominis + 2 1 1
– 12 11 1
S. haemolyticus + 12 12
– 0
Other CoNS + 3 1 1 1
– 6 4 2
S. warnerii + 1 1
– 6 6
S. capitis + 1 1
– 5 5
S. lugdunensis + 0
– 2 2
S. chromogenes + 0
– 2 2
S. schleiferi + 0
– 1 1
S. saprophyticus + 0
– 1 1
S. xylosus + 1 1
– 0
S. simulans + 0
– 1 1
Total 232
Table 2. Correlation between oxacillin agar dilution with
a resistance breakpoint of ‡ 0.5 mg ⁄L, Etest, and the
presence of the mecA gene
Agar dilutiona Etestb
+ ) + )
mecA
+ 122 3 125 125 0 125
– 0 107 107 6 101 107
122 110 232 131 101 232
aSensitivity 97.6%, specificity 100%.
bSensitivity 100%, specificity 95.4%.
Research Note 463
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 459–470
susceptible, but full correlation was achieved
among all the other species.
The findings confirm that, among the species
encountered commonly, the NCCLS oxacillin
breakpoint of ‡ 0.5 mg ⁄L results in correct classi-
fication of CoNS as oxacillin-resistant or -suscept-
ible in most cases.
Etests correlated well with PCR for detection of
oxacillin resistance in the CoNS isolates, but six of
102 mecA-negative isolates were classified falsely
as resistant. Huang et al. [19] found discrepancies
between Etest and agar dilution when testing
CoNS. Etest results were skewed towards MICs of
oxacillin higher than these given by agar dilution.
Both Weller et al. [10] and Frebourg et al. [20]
found major discrepancies when comparing Etest
with PCR, but the results would have been
improved if the resistance breakpoint had been
lowered from 2 to 0.5 mg ⁄L.
Six reports have either proposed revised cri-
teria for oxacillin susceptibility [2,8] or confirmed
[11,14–16] that the new NCCLS oxacillin
breakpoint [17] classifies most of the commonly
encountered species of CoNS correctly as
oxacillin-susceptible or -resistant, but among
the more uncommon CoNS species, the oxacillin
agar dilution test can lead to the incorrect
classification of mecA-negative isolates as oxacil-
lin-resistant. There are, however, small discrep-
ancies among these studies, which may be
caused by differences between the isolates ana-
lysed or problems with the difficult CoNS spe-
ciations [14]. Overall, it seems that the current
NCCLS oxacillin breakpoint recommendation
will categorise accurately the CoNS species
encountered commonly. However, it is recom-
mended that isolates of CoNS should be identi-
fied phenotypically and oxacillin resistance
should be confirmed with PCR for isolates from
patients with serious infections when the choice
of antibiotic is crucial [14,15].
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A B S T R A C T
Brevibacterium has been reported as a rare cause of
implanted-device infection. In two cases of recur-
rent Brevibacterium casei bacteraemia associated
with infection of surgically implanted intravascu-
lar devices, relapse occurred 2 and 5 months,
respectively, after completion of therapy with
vancomycin via the infected catheter. A second
intravenous antibiotic therapy course by the
antibiotic-lock technique led to bacteriological
cure in one patient. Molecular typing results
demonstrated that the recurrent bacteraemia
was caused by the same strain. Implanted-device
removal may be necessary, in addition to appro-
priate antibiotics, for successful management of
such infections.
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Brevibacterium spp. are non-motile, non-spore
forming, catalase-positive, aerobic Gram-positive
bacilli. They are part of the normal flora of the
skin and adjacent structures, but have been
reported only rarely as causes of human infection,
including endocarditis [1], continuous ambula-
tory peritoneal dialysis peritonitis [2] and bacter-
aemia in compromised hosts with long-term
intravenous devices [3–8]. Other habitats include
raw milk, cheese and animal sources. The genus
Brevibacterium contains at least eight species
(B. linens, B. casei, B. epidermidis, B. iodinum,
B. mcbrellneri, B. otitidis, B. avium and B. paucivo-
rans [9]). Identification to the genus level is
achieved easily with commercial identification
panels, but species identification requires addi-
tional biochemical tests, fatty acid analysis or
genotyping.
Management of catheter-related bloodstream
infection varies according to the type of catheter
involved and the causative pathogen. Removal of
the infected catheter in case of complicated
bacteraemia is consensual [10]. However, for
tunnelled or implanted catheter-related infection,
other factors, including the type of pathogen, local
signs of infection, and the severity of infection are
involved in the decision whether or not to remove
the catheter. Conservative intravenous antibiotic
therapy associated with an antibiotic-lock is
recommended only for uncomplicated bacterae-
mia caused by organisms of low virulence [6].
Table 1 summarises the clinical features of two
unusual cases of recurrent bacteraemia caused by
B. casei that were associated with infected long-
term intravascular access. The first patient was a
43-year-old woman, who suffered from Crohn’s
disease and developed pelvic entero-cutaneous
fistulisations. This required total colectomy with
discharge jejunostomy, which was complicated by
chronic entero-cutaneous fistulae. Since this time,
she received total parenteral nutrition through a
totally implantable intravenous port (Port-
A-Cath). Five years later, she presented with
recurrent pyrexia. The second patient was a
31-year-old man with an implanted Hickman
catheter who became febrile (38.5 C) during
haemodialysis. He had no specific symptoms
and physical examination was normal, with no
sign of catheter infection and no noticeable
inflammatory syndrome. In both cases, blood
culture yielded B. casei, and intravenous therapy
with vancomycin was initiated. Both patients
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